The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.
about
Buprenorphine for treating cancer painBuprenorphine for treating cancer painTransdermal buprenorphine - a critical appraisal of its role in pain management.Buprenorphine and opioid antagonism, tolerance, and naltrexone-precipitated withdrawalThe Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute PainThe use of high dosages of transdermal buprenorphine for pain management in palliative cancer patients: a case study.Pain management in multiple myeloma.Intentional intrathecal opioid detoxification in 3 patients: characterization of the intrathecal opioid withdrawal syndrome.Systematic review of adverse events of buprenorphine patch versus fentanyl patch in patients with chronic moderate-to-severe pain.Buprenorphine for cancer pain: is it ready for prime time?Treatment Considerations for Cancer Pain: A Global Perspective.Pharmacological options for the management of refractory cancer pain-what is the evidence?Transdermal buprenorphine and fentanyl patches in cancer pain: a network systematic review.Multidimensional Treatment of Cancer Pain.Options for Treating Pain in Cancer Patients with Dysphagia.A comparison of oral controlled-release morphine and oxycodone with transdermal formulations of buprenorphine and fentanyl in the treatment of severe pain in cancer patients.Adult cancer pain.The use of transdermal buprenorphine to relieve radiotherapy-related pain in head and neck cancer patients.Fentanyl Suppresses the Survival of CD4+ T Cells Isolated from Human Umbilical Cord Blood through Inhibition of IKKs-mediated NF-κB Activation.A successful switch from transdermal fentanyl to transdermal buprenorphine in a patient with neuropathic pain: a case report.
P2860
Q24197553-396F9FE9-6FDD-41EC-BD8A-24CA3284F184Q24204011-EC39E517-76CF-456C-AC0E-256971A62B97Q34418193-FDCC1897-7269-4936-9157-8EA789D3AA86Q34552092-ACC80C30-2EE6-41D4-A495-361D3E9FACFFQ35804625-7476CF56-79CD-4379-9046-C6EDBB582B6BQ36797096-D680C1FE-DA6C-4102-963B-DEF3684F0E0BQ37705421-0CD638A4-DFE9-461B-BBB9-EFADD2A7AF57Q38038363-C1A022A4-8DCC-4BFD-8DEF-D2FCBC2C2F2BQ38198100-D479F45A-E941-4D26-9E14-6E73FC9823F6Q38243938-35E49401-0C46-4CCB-A6A5-F9585EE10B10Q38282157-03C78DCA-2713-4827-8415-F49F8D01A311Q38370071-D19817E6-6EFD-49D5-AC73-056C8CFF2DA9Q38399076-8AE9BFF8-FAFA-4265-B710-B58B6EB354C1Q39144886-F3E1E3A2-83F2-42C3-A7AA-9A22A29B5F4FQ39155742-F1BF276D-C7FF-4ED0-B29D-0AF153402A02Q41545441-6130A75B-EC6C-4299-A112-536629C5E5CDQ44426953-DD5B315C-DEC5-4E34-BCA9-350EC5E2CD5FQ46553877-99FC91D8-AF34-4993-ABA9-C16BBA0CADCBQ47330511-00C9319B-C2F7-4068-ADC4-F7399512BE85Q48095993-AB111F3E-0956-4281-920C-4B9932052B62
P2860
The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of transdermal bupren ...... in: an expert panel consensus.
@en
The role of transdermal bupren ...... in: an expert panel consensus.
@nl
type
label
The role of transdermal bupren ...... in: an expert panel consensus.
@en
The role of transdermal bupren ...... in: an expert panel consensus.
@nl
prefLabel
The role of transdermal bupren ...... in: an expert panel consensus.
@en
The role of transdermal bupren ...... in: an expert panel consensus.
@nl
P2093
P1476
The role of transdermal bupren ...... in: an expert panel consensus.
@en
P2093
Anna Orońska
Antonio Virizuela Echaburu
Bart Van den Eynden
Euromed Communications meeting
Joseph V Pergolizzi
Juraj Beniak
Ondrej Slama
Rosa María de Faría Fragoso
Sylvester Mordarski
Willem Lybaert
P304
P356
10.1185/03007990902920731
P407
P577
2009-06-01T00:00:00Z